BCNU, PROCARBAZINE AND RADIOTHERAPY IN TREATMENT OF ANAPLASTIC GLIOMAS

BCNU、丙卡巴嗪和放射治疗治疗间变性胶质瘤

• 批准号: 6113804
• 负责人: STEVEN K GUDEMAN
• 金额: $ 1.58万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6113804
• 关键词: adult human (21+); carmustine; child (0-11); clinical research; combination cancer therapy; computed axial tomography; drug screening /evaluation; glioma; human subject; human therapy evaluation; neoplasm /cancer chemotherapy; neoplasm /cancer radiation therapy; neuropsychological tests; procarbazine

This project involves children and adults with posterior fossa tumors who do not meet the requirements of Phase III protocols or who had relapses after entry into them. Each patient is followed with reference to CT scan appearance of the lesion, neurologic findings, and Karnofsky functional rating.

该项目涉及患有后颅窝肿瘤的儿童和成人。 谁不符合第三阶段协议的要求，或者谁已经 在进入他们之后复发。每个病人都有参考资料。 对病变的CT扫描表现、神经学表现和卡诺夫斯基 功能等级。